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Abstract
Background: Incidence of type 2 diabetes is high after gestational diabetes mellitus (GDM). We aimed to evaluate
the adherence to follow-up six-weeks postpartum visits in secondary care after GDM and glucose monitoring in
primary care longer than 12–14 months after delivery and the years thereafter. In addition, we examined the
women’s lifestyle after delivery.
Methods: A cross-sectional follow-up survey among women with a history of GDM and their general practitioners
(GP). Rates of attendance at the six-weeks postpartum visit and glucose testing were obtained from hospital records,
over the period 2011–2012. Rates of annual follow-up postpartum glucose testing were assessed by a survey among
their GP’s. Lifestyle of the women on diet and exercise was assessed by questionnaire in 2015.
Results: In total 197 women were eligible for the study. Of these, 156 (79%) attended the six-weeks postpartum visit at
the diabetes outpatient clinic and in 145 (93%) of these women glucose testing was performed. In total 77 (39%) women
responded to the invitation to participate in this study and filled in the lifestyle questionnaire. About one third of the
women met the recommendations for sufficient physical activity. A majority of them did not fulfil the Dutch guidelines
on healthy diet – fruit intake 35.1%, vegetables intake 7.8%. Of the 74 invited GP’s, 61 responded (82%), only 12 (20%)
reported that they had performed a follow-up glucose testing within >12–14 months postpartum. Of these women,
five were tested only in the first year of follow-up, five also in the second year, and two were tested for
three consecutive years.
Conclusions: Despite the high attendance rate of six-weeks postpartum visit and glucose testing, we observed low
rates of longer-term follow-up regarding postpartum glucose testing. Moreover, we found a suboptimal adherence
to healthy lifestyle for women with a history of GDM.
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Background
Gestational diabetes mellitus (GDM) is historically defined as
any degree of glucose intolerance with onset or first recogni-
tion during pregnancy [1]. Although in most women with
GDM glucose intolerance resolves after delivery, women
with a history of GDM are at increased risk of developing
impaired glucose tolerance and type 2 diabetes mellitus
(DM). It has been estimated that the risk of type 2 DM may
be as high as 50–70% in 5–10 years after delivery [2, 3].
Adequate lifestyle interventions may prevent or postpone
the development of type 2 DM. In addition, early diagnosis
and treatment of type 2 DM may contribute to the preven-
tion of long-term DM complications, including cardiovas-
cular- and renal diseases [4]. Therefore, national and
international guidelines recommend follow-up glucose
testing in women with a history of GDM [5, 6]. In
the Netherlands, the 2010 Dutch Society of Obstetrics
and Gynaecology guideline “Diabetes and Pregnancy”
recommends glucose testing six weeks after delivery
and subsequently once a year for the next 5 years [5].
Our department routinely invited all patients to the
Diabetes Centre to attend a six-weeks postpartum
visit. Patients then are referred back to their general
practitioner (GP), who has a central role in our
health-care system and is therefore the most obvious
caregiver to perform annual follow-up glucose testing
and simultaneously to motivate women to adopt and
maintain a healthy lifestyle to prevent type 2 DM.
It is however unclear how well the advices of this
guideline are implemented. To improve early diagnosis
of type 2 DM after GDM, we should first verify how
many GP’s are aware that women with a history of GDM
need annual follow-up glucose testing and take direct re-
sponsibility for follow-up glucose testing. For instance,
do they have a system to track former GDM patients? In
addition, it is important to know whether women with a
history of GDM are aware of the recommended annual
follow-up glucose testing, and take responsibility for vis-
iting their GP once a year out of their own initiative and
change their lifestyle. Successful monitoring depends on
clear guidelines, good implementation in primary and
secondary care, and education of self-management and
adherence of the patient.
Hence, we evaluated the adherence-rate of the follow-
up postpartum visit in secondary care after GDM and
glucose testing longer than > 12–14 months after deliv-
ery and the years thereafter in primary care. We also ex-
amined by questionnaire the lifestyle of the women with
a history of GDM including physical activity and diet.
Methods
Study participants
This study is a cross-sectional follow-up survey of
former women with GDM and their GP’s. All 215
women who were treated for GDM at the University
Medical Center Groningen, with a first visit between
January 2011 and December 2012, were eligible for
participation.
All pregnant women had GDM screening at week 24–28
of gestation if they had one or more GDM risk factors [5].
The World Health Organization 1999 criteria were used to
diagnose GDM (fasting plasma glucose value ≥ 7.0 mmol/l
and/or a two-hour value ≥ 7.8 mmol/l after a 75-g oral
glucose tolerance test (OGTT)) [7]. In accordance with the
standard of care, all women diagnosed with GDM were
referred to the dietician for dietary counselling. If after 1–2
weeks the fasting plasma glucose was > 5.3 mmol/l and/or
postprandial plasma glucose level > 7.8 mmol/l, insulin
therapy was started. Routinely this is stopped after delivery.
Women were invited to visit the outpatient clinic six
weeks after delivery. During this visit, laboratory testing
for blood glucose values, HbA1c, lipid profile, and
microalbumuria was performed and all women received
information about the future risk of developing type 2
DM. Glucose values were evaluated with results of a
75-g OGTT, HbA1c and/or self-monitoring of the blood
glucose (SMBG) values. Women who were breast-
feeding were recommended to perform additional
glucose testing after cessation of breastfeeding. Targets
for treatment were discussed, including weight reduction
and information about healthy lifestyle, and they were
verbally instructed to visit their GP at least annually for
follow-up glucose testing. The GP received a discharge
letter mentioning the increased risk for development of
type 2 DM and a formal advise to invite their patient for
–at least- annual follow-up glucose testing.
For the present study, all the women treated for GDM
between January 2011 and December 2012 were invited,
including women who did not visit the six-weeks post-
partum glucose visit and/or women who did not test
their glucose values at the six-weeks postpartum visit.
Women were not invited to participate if they had a still
birth (n = 2). The GP was invited to fill in a question-
naire when their patient gave informed consent. The
study was conducted in accordance with the guidelines
of the Declaration of Helsinki and Good Clinical
Practice, and approved by the Medical Ethical Review
Committee of the University Medical Center Groningen.
Procedure and data collection
Clinical and demographic data of all eligible women were
obtained from the electronic medical records, including:
age at delivery, ethnicity, family history of DM, previous
GDM, previous infant weighing ≥ 4500 g at birth, pre-
gestational body mass index (BMI), delivery of a large for
gestational age (LGA) infant, requiring insulin during
GDM pregnancy, gestational age at delivery, and data about
the six-weeks postpartum visit and laboratory evaluation.
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Family history of DM was defined as having a first
degree relative with type 2 DM. LGA was defined as a
birth weight above the 90th percentile, adjusted for
gestational age, gender, parity, and ethnicity [8].
Questionnaire women
In August 2015, a letter was sent to all eligible women
outlining the study goals and procedures, together with an
informed consent form, a questionnaire, and a prepaid
envelope. If needed seven weeks later a reminder was sent
containing the same materials as the first invitation. The
questionnaire comprised questions on educational level,
breast feeding, and life style factors, including body
weight, smoking, alcohol use, exercise, and diet.
Educational level was defined as low (primary education
or intermediate vocational education), middle (higher sec-
ondary education), and high (higher vocational education
and university). Duration of breastfeeding was labelled
into four categories: 0 months, < 3 months, 3 to < 6 months,
and ≥ 6 months.
Smoking status was defined as never smoker, ex-
smoker or current smoker (1–6 or 6–20 cigarettes/day).
Alcohol consumption was defined as ≤ 1 drinks/day
(light drinker) and > 1–2 drinks/day (moderate drinker).
Weight loss and weight gain were defined as a difference
in weight of ≥ 5 kg compared to pre-pregnancy weight.
Exercise behaviour was assessed using the validated
Short Questionnaire to Asses Health enhancing physical
activity (SQUASH) questionnaire [9]. Women were
asked to estimate commuting activities, leisure-time and
sport-activities, household activities, and activities at
work or school. According to the Dutch guidelines for
healthy exercise, adults – 18 to 54 years – should have a
moderate level of physical activity for at least half an
hour, on at least five days a week [10].
According to the “Dutch guidelines for a healthy diet
2006” [11] we asked the women questions about their
diet. These guidelines are translated by the Netherlands
Nutrition Centre into the “Food Choice guidelines” and
are formulated in terms of foods with two goals, to pro-
vide a nutritionally adequate diet containing all recom-
mended macro- and micronutrients and to prevent
chronic diseases [12]. The guideline contains five basic
food groups which deliver the essential micro-and macro
nutrients. These basic food groups are divided into three
subgroups: foods with a positive, neutral, and negative
effect on health. The subgroup criteria to classify foods
are based on four nutrients that increase the risk of
chronic diseases: saturated fatty acids, trans unsaturated
fatty acids, added sugar, sodium, and one nutrient that
decrease the risk: dietary fiber [12]. According to the ba-
sics foods groups and three subgroup criteria we asked
women how much they eat of each basic food group and
from which subgroup they mostly eat. For example:
“How many parts of fruit do you eat per day?” “Which
category is most consistent with your choice? A. Unpro-
cessed fruit B. Pureed fruit or C. Fruit with added sugar/
syrup”. The reported food choices were compared with
the recommended amounts and the positive and neutral
food groups were considered good [12]. The women
were also asked about their knowledge of the “Food
Choice guidelines” and their eating moments (“How
many times per week do you eat breakfast, lunch, or din-
ner?” “How many times do you eat or drink per day?”).
The Dutch Health Council advices seven eat/drink mo-
ments per day with a low intake of foods and drinks
with easily fermentable sugars and drinks high in food
acids (without the use of water, thee- and coffee (without
sugar), or milk) [11].
Questionnaire general practitioners
Women were asked to give informed consent to send a
questionnaire also to their GP. In November 2015, the
eligible GP’s received a letter outlining the study, a ques-
tionnaire, and a copy of the informed consent form of
their patient. If needed seven weeks later a reminder was
sent containing the same materials as the first invitation.
The questionnaire included questions about the annual
follow-up screening. The GP was asked if he/she sent an
annual reminder to their patient and if the patient has
visited the annual postpartum controls (if the answer
was no, “can you give a reason why your patient did not
visit the annual postpartum controls”? If the answer was
yes, “How many times did your patient visit the annual
postpartum testing?”, “Did you repeat life style advices
during the postpartum testing?”, and “Did your patient
develop type 2 DM?”).
Statistical analyses
All analyses were conducted using statistical package
IBM SPSS Statistics (version 22.0. Armonk, NY: IBM
Corp). Continuous data are given as mean ± standard de-
viation (SD) or as median and inter quartile range [IQR]
in case of skewed distribution. Categorical data are given
as number and percentage. Differences between the
groups were tested using Student’s unpaired t-test for
continuous data or Mann–Whitney U Test in case of
skewed distribution. For categorical data Chi-square or
Fisher’s exact test were used.
All p-values are two-tailed, and p-values below 0.05
were considered statistically significant.
Results
In total 213 women were invited to participate in the
study, 16 women had moved (Fig. 1). The most important
clinical and demographic characteristic of the 197 eligible
women (77 responders (39%), 120 non-responders (61%))
are summarized in Table 1. The women who responded
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were more often Caucasian (87%), and they more
frequently had a previous infant weighing ≥ 4500 g at birth
(14%). The women in the non-responder group had a
slightly higher pre-gestational BMI and were more often
obese (≥30 kg/m2) compared with the responder group.
There were no differences in maternal age, family history
of GDM, previous GDM, insulin requirements, LGA
infant at delivery, and gestational age at delivery.
Of the 197 eligible women, 156 (79%) attended the six-
weeks postpartum office visit at the diabetes outpatient
clinic in secondary care. More women in the responder
group attended this postpartum office visit compared with
the non-responders group. In 145 (93%) women who
attended the postpartum visit glucose testing was per-
formed. In total 62 (43%) women underwent a postpartum
75-g OGTT. Based on the postpartum 75-g OGTT,
nineteen women had impaired glucose tolerance (2-h
value after 75-g OGTT between ≥ 7.8 and 11.0 mmol/l)
and one woman was diagnosed with type 2 DM. In
122 (84%) women HbA1c was measured. In 58 women
who underwent a 75-g OGTT, HbA1c was also measured.
In 19 (14%) women only SMBG was used to interpreted
glucose status. HbA1c and SMBG were used for glucose
status because of breastfeeding at time of the six-weeks
postpartum visit (n = 58), patient declined the OGTT
(n = 7), illness (n = 2), or the reason was unknown (n = 16).
Almost 87% of the GP’s received a discharge letter, 22
(11%) women received a copy of this discharge letter.
Questionnaire women
Table 2 summarizes the follow-up lifestyle characteristics
of the 77 women who responded to the questionnaire.
The mean follow-up time was 3.5 ± 0.6 years. The me-
dian BMI was 26.5 [IQR 23.4-30.1] kg/m2 and is com-
parable with their pre-gestational BMI of 26.4 [IQR
22.9-30.6] kg/m2. More women lost weight (25%)
(≥5 kg) than gained weight (20%) (≥5 kg) compared with
their pre-gestational weight. Knowledge of the national
recommendations for healthy exercise and the Dutch
Food Choice guidelines was limited.
Questionnaire physician’s
Outcomes of the annual follow-up glucose testing at the
GP are summarized in Table 3. In total 74 GP’s were in-
vited to participate in the study, and 61 GP’s (82%)
responded. Of the 61 GP’s, 12 GP’s reported that they
performed follow-up glucose testing within >12–14
months after delivery. Only two women were tested for
three consecutive years. Reasons GP’s provided for not
screening are also summarized in Table 3.
Discussion
In this follow-up survey of women with a history of GDM
and their GP, we found high rates of the six-weeks post-
partum visit and glucose testing at the diabetes outpatient
clinic. However, we found low rates of longer-term follow-
up postpartum glucose testing in primary care.
Moreover, we found suboptimal performance of adher-
ence to a healthy lifestyle for women with a history of
GDM, particularly with respect to exercise and to a lesser
extent regarding diet. Most of the GP’s also did not provide
lifestyle advices at the annual follow-up glucose testing.
During the six-weeks postpartum office visit a note-
worthy number of women tested with a 75-g OGTT
were found to have impaired glucose tolerance and one
woman was diagnosed to have type 2 DM. This finding
indicates that a number of women are in an advanced
stage of developing type 2 DM. Studies suggest that the
association between GDM and type 2 DM can be ex-
plained by the fact that many of the risk factors for both
disorders are the same, including high BMI, family his-
tory of diabetes, and ethnic origin [2, 3]. The prevalence
of GDM is increasing worldwide and former GDM
Fig. 1 Flow-chart study population
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women are for several years at risk to develop type 2 DM.
Therefore, the low long-term rates are a missed opportun-
ity to postpone obesity and type 2 DM, disease which carry
a high burden for the individual patient and for society.
There is limited published data on the long-term
follow-up testing in primary care of women who have
had GDM. Two recent studies [13, 14], conducted in the
United Kingdom, investigated the long-term follow-up
testing of women with a history of GDM. The first study
demonstrated that during a 5-year period around 20% of
the 718 women with a history of GDM had long-term
follow-up glucose testing and only three (0.4%) women
were followed-up every year [14]. Another study showed
that of the 233 included women, 34% had glucose testing
in the first year postpartum, 12% (16 of the 131) in the
second year and 18% (8 of the 45) 3 years after delivery
[13]. These findings are in line with the rates of long-
term follow-up glucose testing found in our study.
There are several potential explanations for the low
long-term follow-up postpartum testing rates. This study
indicates that follow-up of women with GDM is insuffi-
ciently incorporated in the primary care system. Possible
reasons for this hampered follow-up system may include
a lack of agreed protocols, insufficient or unclear com-
munication by the treating physician in secondary care,
and a lack of sufficient call- and tracking systems in
Dutch family practices. Although the Dutch Society of
Obstetrics and Gynaecology guideline 2010 “Diabetes
and Pregnancy” recommends glucose testing six-weeks
after delivery and subsequently once a year for the next
5 years, such follow-up glucose testing was added to GP
guidelines only in 2013 [15].
Table 1 Pre-gestational and gestational characteristics of the eligible study participants (period 2011–2012) according to survey
responders and non-responders
Characteristics Total Responder P-value*
Yes No
N (%) 197 77 (39.1) 120 (60.9)
Age at delivery (yrs) 32.2 ± 4.9 32.8 ± 5.0 31.9 ± 4.8 0.173
Family history of DM, n (%) 77 (41.8) 34 (47.2) 43 (38.4) 0.236
Previous GDM, n (%) 10 (5.1) 6 (7.8) 4 (3.3) 0.193
Previous infant weighing
≥ 4500 g at birth, n (%)
17 (8.6) 11 (14.3) 6 (5.0) 0.024
Pre-gestational BMI (kg/m2) 27.6 [24.1-31.2] 26.4 [22.9-30.6] 27.9 [24.3-32.0] 0.040
Pre-gestational BMI, n (%)
< 25 kg/m2 61 (32.4) 27 (37.5) 34 (29.3) 0.236
25–29.9 kg/m2 61 (32.4) 25 (34.7) 36 (31.0)
≥ 30 kg/m2 66 (35.1) 20 (27.8) 46 (39.7)
Requiring insulin during pregnancy, n (%) 90 (45.7) 32 (41.6) 58 (48.3) 0.352
Gestational age at delivery (wks) 38.3 [38.0-39.6] 38.4 [38.0-39.7] 38.1 [37.7-39.5] 0.070
LGA infant, n (%)‡ 41 (20.8) 16 (20.8) 25 (20.8) 0.993
Postpartum visit at the DM outpatient
clinic, n (%)
156 (79.2) 71 (92.9) 85 (70.8) 0.001
Postpartum glucose testing, n (%)
OGTT 62 (42.8) 31 (43.7) 31 (36.5) 0.558
HbA1c** 122 (61.9) 57 (74.0) 65 (53.3)
SMBG 19 (13.1) 8 (11.3) 11 (12.9)
Not test 11 (7.1) 3 (4.2) 8 (9.4)
Discharge letter sent to the GP, n (%) 171 (86.8) 68 (88.3) 103 (85.8) 0.616
Copy of the discharge letter sent to women, n (%) 22 (11.2) 12 (15.6) 10 (8.3) 0.115
Abbreviations: BMI body mass index, DM diabetes mellitus, GDM gestational diabetes mellitus, LGA large for gestational age, GP general practitioner, OGTT oral
glucose tolerance test, SMBG self-monitoring of the blood glucose
Data are expressed as mean ± SD, median [IQR], or proportion n (%)
Data with respect to family history of diabetes and pre-gestational body mass index are missing, in 13 (6.6%) and 9 (4.6%) of the women, respectively
**In 58 women who underwent a 75-g OGTT, Hb1Ac was also measured
‡Large for gestational age was defined as a birth weight above the 90th percentile, adjusted for gestational age, gender, parity, and ethnicity
*P-values were based on Student’s unpaired t-test (non-skewed continuous variables), Mann–Whitney U-Test (skewed continuous variables) or chi-square test or
fisher’s exact test (categorical variables)
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There may be limited knowledge and reduced aware-
ness of the importance of postpartum screening among
GDM women. A number of GP’s reported that also the
women declined testing and did not respond to a follow-
up invitation despite sending a reminder. This is remark-
able as during the six-week postpartum visit, all women
have verbally received information about their future
risk of type 2 DM and they were instructed to visit their
GP at least annually for follow-up glucose testing. How-
ever, only a small number received a copy of the dis-
charge letter sent to their GP, which summarized these
verbal communications, and none have received add-
itional written information on the risk of development
of type 2 DM and adoption of a healthy lifestyle. Studies
have demonstrated that lifestyle modifications including
weight loss, healthy diet, and moderate exercise can re-
duce the risk of developing type 2 DM in high risk sub-
jects [16, 17] and also in women with a history of GDM
[18–20]. For this reason, during the six-weeks postpar-
tum visit all women with a history of GDM received in-
formation about the benefits of weight management and
moderate physical activity. In this study all women re-
ceived a life-style questionnaire to examine the life-style
of women with a history of GDM. The women who
responded at the questionnaire were less often obese,
had higher rates of a previous infant weighing ≥4500 g
at birth, and more women attended the six-weeks post-
partum visit and glucose testing compared with the non-
responder group. These findings, may suggest that the
responders group is more interested and aware about
the importance of lifestyle changes compared with the
non-responder group. However, also in the responder
group only one third of the women met the recommen-
dations of physical activity and there were suboptimal
levels of dietary intake, for instance a low intake of fruit
and vegetables. Moreover, most of the women were
overweight (BMI ≥25-29.9 kg/m2) or obese (BMI
≥30 kg/m2). A positive finding was the fact that more
women lost weight than gained weight compared with
their pre-pregnancy weight. A few studies have investi-
gated the health status and lifestyle modifications in
women with a history of GDM [21–27]. In analogy to
Table 2 Follow-up characteristics of the survey responders
Follow-up characteristics N = 77
Postpartum (yrs) 3.5 ± 0.6
Age (yrs) 36.3 ± 5.0




Duration of breastfeeding, n (%)
0 month. 24 (31.2)
< 3 months. 26 (33.8)
3 to 6 months. 11 (14.3)
> 6 months. 14 (18.2)
Current smoker, n (%) 17 (22.1)
Alcohol consumption, n (%)
Non-drinker 29 (37.8)
≤ 1 drink/d 46 (59.7)
> 1–2 drinks/d 2 (2.6)
Weight
BMI (kg/m2) 26.5 [23.4-30.1]
BMI, n (%)
< 25 kg/m2 24 (31.2)
25–29.9 kg/m2 29 (37.7)
≥ 30 kg/m2 21 (27.3)
Weight gain, n (%)† 15 (19.5)
Weight loss, n (%)† 19 (24.7)
Physical Activity
Knowledge of Dutch recommendations
on physical activity, n (%)
12 (15.6)
Active 30 min 5 days/week, n (%) 27 (35.1)
Diet
Knowledge of Dutch Food choice guidelines, n (%)
Yes 40 (51.9)
No, not exactly 31 (40.3)
No, never heard of it 6 (7.8)
Eating three meals p/d, n (%) 55 (71.4)
Max. two snacks p/d, n (%) 67 (87.0)
Fish two times p/wk, n (%) 15 (19.5)
Meeting the recommendations for basic food groups
Fruit, n (%) 27 (35.1)
Vegetables, n (%) 6 (7.8)
Bread and grain products, n (%) 1 (1.3)
Potatoes, rice, pasta, legumes, n (%) 5 (6.5)
Milk (products), n (%) 28 (36.4)
Cheese, n (%) 43 (55.8)
Table 2 Follow-up characteristics of the survey responders
(Continued)
Meat, fish, poultry, eggs, meat
substitutes, n (%)
10 (13.0)
Oils and soft margarines, n (%) 25 (32.5)
Drinks, n (%) 27 (35.1)
Abbreviations: BMI body mass index. Data are expressed as mean ± SD, median
[IQR], or proportion n (%)
Data with respect to body mass index and breastfeeding are missing, in 3 (3.9%)
and 2 (2.6%) of the women, respectively. †Weight loss since pregnancy was defined
as≥ 5 kg and weight gain as≥ 5 kg
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our study, these studies showed that diet and physical
activity levels rarely met the recommendations [22, 23,
26, 27].
Even though most of the women were highly educated,
we found a suboptimal performance of adherence to a
healthy lifestyle. There are several barriers for women
with a history of GDM to adopt a healthy lifestyle in-
cluding time, financial constraints, child care, lack of
motivation, and lack of social support [28]. These bar-
riers are also found in women with the same age without
a history of GDM [22].
In the Dutch health-care system, the GP could be a
good motivator for women to adopt a healthier life-
style [29]. However, the GP’s did not reinforce a
healthier lifestyle as most of them did not provide
such advices at the annual follow-up. This study and
previous studies indicated that there is need for better
lifestyle awareness and coaching in primary care, in-
cluding advice about diet and physical activity. With
our current health-care system we are missing oppor-
tunities to interfere in obesity and type 2 DM devel-
opment. Successful monitoring depends on a good
implementation in secondary and primary care and
education of self-management and adherence of the
patient. There are several recommendations for the
organization of care to expand and improve the long-
term follow-up in former GDM women.
First, the internist can improve care by sending a
discharge letter to the GP and a copy of the letter to the
patient, including written information (a brochure)
about the future risk of type 2 DM. Secondly, the GP
can denote a previous GDM patient carrying an in-
creased cardiovascular risk and connect them to a track-
ing system in the GP practices and send postnatal
reminders to women. A study in South Australia has
shown that a GDM Recall Register for former GDM
women – sending a reminder 15 months after the ex-
pected delivery date - is successful in recruiting women
to remind them that they should continue to have their
blood glucose checked over the long term [30]. At last,
another place for health promotion and raise further
awareness could be the Early Childhood Centers.
Women visit the Early Childhood Center regularly with
their baby’s (0–4 years), and their nurses can help to rec-
ommend the mother to pursue follow-up care by their
GP. Regional lifestyle programs/self-management pro-
grams can be offered by the Early Childhood Centers,
for example in group classes.
Strengths and limitations
Strengths of the study are the evaluation of postpartum
glucose visits in secondary care and additional the an-
nual long-term postpartum glucose testing in primary
care. To our knowledge this is the first study in the
Netherlands which investigated the glucose screening of
women with a history of GDM.
This study has several potential limitations. This study
was conducted at only one institution with a relative
small sample size. Therefore, the total number of women
with a history of GDM who responded was too low to
evaluate the type 2 DM incidence. Furthermore, we have
no information about lifestyle factors of the women
before their pregnancy. For this reason, we cannot deter-
mine to what extent the educational issues connected to
GDM motivated patients to change lifestyle for example
lose weight. Finally, in most of the guidelines an OGTT
is recommended for blood glucose testing, because the
OGTT has a high sensitivity compared with other
screening methods. In our national guideline the OGTT
is not the standard for blood glucose screening
Table 3 Annual glucose screening at the general practitioner
GP responders N = 61*
Annual postpartum control, n (%) N = 12 (20.0)**
Received a discharge letter from
secondary care, n
11
Patient in a re-call system, n 4
Total number of annual glucose screenings, n
1 year follow-up 5
2 years follow-up 5
3 years follow-up 2
Provided lifestyle advices, n 4
Total women diagnosed with
type 2 diabetes, n
1
No annual postpartum control, n (%) N = 49 (80.0)***
Received a discharge letter from
secondary care, n
43
Patient in a re-call system, n 15
Reasons for not screening, n
Patient declined testing 1
GP did not know testing is needed 4
Patient not in a call system 1
GP did not see the patient, despite
a reminder
4
Patient had a second pregnancy
within 1 year
2
Patient had other GP at time of
GDM pregnancy
4
Controls at endocrinologist 5
Reason unknown 28
Abbreviations: GP general practitioner, GDM gestational diabetes mellitus
Data are expressed as proportion, n (%)
*Total general practitioners responded
**Total general practitioners responded and who screened their patient within
12–14 months after delivery
***Total general practitioners responded and who did not screened their patient
within 12–14 months after delivery
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postpartum, because the OGTT screening method is
time consuming and not patient-friendly.
Conclusions
In conclusion, this study demonstrated that in women
with a history of GDM postpartum follow-up care was
far from optimal and showed a striking discrepancy with
current guidelines. Long-term postpartum follow-up
clearly requires improvements in the Netherlands, to
early diagnose pre-diabetes or type 2 DM and more im-
portantly to pay attention to preventive strategies. The
improvement of long-term follow-up testing could be
realized by marking GDM patients and connect them to
a yearly recall-system. Also a better communication
between primary and secondary care is needed. Finally,
awareness among women with a history of GDM will
probably surface a healthier lifestyle and at least de-
crease the low rates at the postpartum visit in primary
care. There is clearly more need for lifestyle coaching
programs/self-management for women with a history of
GDM to adopt a healthy lifestyle and make them aware
about the risk of type 2 DM.
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